We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Date
Sponsor content
1144 result(s) found, displaying 101 to 110
-
Cancellation by sponsorRequested by Sandoz Pty Ltd
-
Australian public assessment report (AusPar)Jubbonti (a biosimilar to Prolia), and Wyost (a biosimilar to XGEVA), were approved to improve bone density and to reduce bone fracture risk as a consequence of disease or medications that weaken bones.
-
Cancellation by sponsorRequested by Sandoz Pty Ltd
-
Cancellation by sponsorRequested by Sandoz Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LENALIDOMIDE SANDOZ lenalidomide 2.5 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LENALIDOMIDE SANDOZ lenalidomide 7.5 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LENALIDOMIDE SANDOZ lenalidomide 20 mg capsule blister pack.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TICAGRELOR SANDOZ ticagrelor 90 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BTC DESVENLAFAXINE desvenlafaxine 50 mg extended release tablet blister pack.